HATCHPAK IB H120
HATCHPAK IB H120
Authorised
- Avian infectious bronchitis virus, type Massachusetts, strain H120, Live
Product identification
Medicine name:
HATCHPAK IB H120
Hatchpak IB H120 Diepgevroren suspensie voor vernevelsuspensie
Hatchpak IB H120 Suspension congelée pour suspension pour inhalation par nébuliseur
Hatchpak IB H120 Gefrorene Suspension zur Suspension für einen Vernebler
Active substance:
- Avian infectious bronchitis virus, type Massachusetts, strain H120, Live
Target species:
-
Chicken (one day-old chick)
Route of administration:
-
Oculonasal use
Product details
Active substance and strength:
-
Avian infectious bronchitis virus, type Massachusetts, strain H120, Live3.70/log 10 50% embryo infective dose1.00Dose
Pharmaceutical form:
-
Concentrate for nebuliser solution
Withdrawal period by route of administration:
-
Oculonasal use
- Chicken (one day-old chick)
-
All relevant tissuesno withdrawal periodWithdrawal period is 0 days
-
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QI01AD07
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Valid
Authorised in:
-
Belgium
Package description:
- Container of liquid nitrogen of canisters of 4 yellow ampoules of 15,000 doses
- Container of liquid nitrogen of canisters of 4 yellow ampoules of 10,000 doses
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Full application - Known active substance (Article 12(3) of Directive No 2001/82/EC)
Marketing authorisation holder:
- Boehringer Ingelheim Animal Health Belgium S.A.
Marketing authorisation date:
Manufacturing sites for batch release:
- Boehringer Ingelheim Animal Health France
Responsible authority:
- Federal Agency For Medicines And Health Products
Authorisation number:
- BE-V443082
Date of authorisation status change:
Reference member state:
-
France
Procedure number:
- FR/V/0171/001
Concerned member states:
-
Belgium
-
Bulgaria
-
Cyprus
-
Czechia
-
Germany
-
Greece
-
Hungary
-
Italy
-
Latvia
-
Lithuania
-
Netherlands
-
Poland
-
Romania
-
Slovakia
-
Slovenia
-
United Kingdom (Northern Ireland)
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
How useful was this page?:
